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The impact of organic molecules on the crystallization of inorganic materials is important in areas 
including biomineralization,1, 2 hydrometallurgical processing,3 and crystal engineering4. In the context 
of biomineralization, it is well established that proteins rich in glutamic and aspartic acid residues are 
found associated with biologically formed materials, particularly calcium carbonate.5, 6 It has been 
shown, for example, that proteins rich in glutamic acid are associated with amorphous calcium 
carbonate in an ascidian skeletal structure, whereas proteins containing aspartic acid residues are 
associated with the crystalline component.7  In vitro studies of these proteins showed significant impact 
on the crystal growth of calcium carbonate, consistent with their location in the organism. Based on 
such observations, a number of reports describe the synthesis of acidic peptides,8-10 and other 
polycarboxylates,11 designed to interact with calcium carbonate. Despite this activity, a direct 
relationship between additive structure, crystallization environment and the polymorph and morphology 
of the crystalline product is yet to be elucidated.12  
Our approach to this problem is based on our previous studies of crystal growth modifiers with 
systematically altered structures.13 The amino acid components found to be active in Nature, are placed 
on a simple, readily synthesized, structure that is completely distinct from the natural system. In this 
case, we have chosen the calix[4]arene macrocycle as a framework to which the active moieties can be 
attached. Using well established chemistry, the calix[4]arene can be “locked” in the cone conformation, 
directing the amino acids to one side of the additive molecule.14 The conformational freedom of the 
molecule is thus somewhat limited. Ultimately, the impact of a range of subtly varying additives upon 
the crystal growth of a number of different inorganic systems will be used to establish structure-activity 
relationships that can be tested against natural and artificial additives with different structures.  
Macrocyclic crystal growth modifiers have not been widely studied; examples include phosphonate-
functionalised aza macrocycles as barium sulfate modifiers,15, 16 and calcium carbonate growth at 
carboxylated porphyrin monolayers.17 Of particular relevance here is the recent report of calcium 
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carbonate crystal growth under carboxylated calixarene monolayers at the air-water interface.18-20 The 
outcome of this work, in agreement with other recent reports on calcium carbonate growth at 
monolayers,21 was that the crystal growth is not controlled by a template effect of the specific calixarene 
or monolayer structure.19 We have found that a calix[4]arene functionalized with four aspartic acid 
moieties is appreciably water-soluble, and we have recently reported the impact of this additive upon the 
crystal growth of calcium carbonate and calcium oxalate.22 Here, we report the synthesis of the aspartic 
and glutamic acid functionalized calix[4]arenes, and their impact on the crystal growth of calcium 
carbonate, calcium oxalate and barium sulfate.  
EXPERIMENTAL SECTION 
5,11,17,23-Tetra-tert-butyl-25,26,27,28-tetrakis(chlorocarbonylmethoxy)calix[4]arene was 
























Calixarene syntheses – Aspartate functionalized additive 1. Dimethyl aspartate hydrochloride 
(5.20 g, 26.3 mmol) was dissolved in anhydrous dichloromethane (80 mL) at -10°C and triethylamine 
(13 g, 128 mmol) was added with stirring. The p-tert-butylcalix[4]arene tetrakis(acid chloride) (2.2g, 
2.34 mmol) was dissolved separately in anhydrous dichloromethane (20 mL) and then added at once to 
the other reactants. The reaction was allowed to reach room temperature and left stirring overnight. The 
mixture was filtered to remove triethylamine salts and then the filtrate was concentrated by distillation 
under reduced pressure. The residue was then dissolved in dichloromethane (200 mL), washed with 
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hydrochloric acid (1 M, 3 x 100 mL), sodium hydroxide (0.5 M, 2 x 100 mL), hydrochloric acid again 
(1 M, 100 mL), water (100 mL) and finally brine (100 mL). After drying over magnesium sulfate the 
filtrate was distilled under reduced pressure to yield the methyl ester of 1 as a white solid. This was 
recrystallised from tetrahydrofuran/toluene and the product washed with cold diethyl ether (920 mg, 
27% yield). (Found: C, 62.70; H, 7.09; N, 3.81. C76H100O24N4 requires C, 62.80; H, 6.93; N, 3.85%). 
NMR (CDCl3): 1H, δ 1.08 (s, 36 H, But), 2.97 (m, 8H, CHCH2COO), 3.21 (d, 4H, Heq ArCH2Ar), 3.66 
(s, 12H, OCH3), 3.73 (s, 12H, OCH3), 4.58 (d, 8H, OCH2CO), 4.75 (d, 4H, Hax ArCH2Ar), 5.00 (m, 4H, 
CHN), 6.75 (s, 8H, aromatic CH), 7.97 (d, 4H, NH); 13C, δ 32.02 (Me3C), 32.46 (ArCH2Ar), 34.54 
(Me3C), 36.62 (CHCH2COO), 49.38 (CHN), 52.58, 53.33 (OMe), 74.72 (OCH2CO), 126.27, 126.44, 
133.26, 133.62 (aromatic CH), 146.17, 153.83 (aromatic C), 170.71 (CONH), 171.96 (COOMe). 
The methyl ester of 1 (1.00 g, 0.69 mmol) was heated at reflux in methanol (130 mL) and then a 
solution of potassium carbonate (2.1 g, 15.2 mmol) in water (16.4 mL), was added at once. Heating was 
continued for 2.5 hours. Upon cooling to room temperature, the methanol was removed by distillation 
under reduced pressure. The remaining solution was made up to 150 mL with water and then adjusted to 
pH 2 with 1M hydrochloric acid. The solution was extracted with ethyl acetate (4 x 60 mL) and after 
drying the combined extracts, the solvent was removed by distillation under reduced pressure. The solid 
was recrystallised from thf/toluene and then washed with cold ether to yield 1 (872 mg, ~90% yield). 
(Found: C, 59.88; H, 6.73; N, 3.66. C68H84O24N4.2H2O.thf requires C, 59.66; H, 6.68; N, 3.86%). 
Glutamate functionalized additive 2. The methyl ester of 2 was synthesized following the procedure 
described above to give the product as a white powder in 50% yield. (Found: C, 63.52; H, 7.14; N, 3.39. 
C80H108O24N4 requires C, 63.64; H, 7.21; N, 3.71%). NMR (CDCl3): 1H, δ 1.07 (s, 36 H, But), 2.01-2.23 
(m, 8H, CHCH2CH2), 2.24-2.35 (m, 8H, CH2CH2COO), 3.21 (d, 4H, Heq ArCH2Ar), 3.66 (s, 12H, 
OCH3), 3.70 (s, 12H, OCH3), 4.54 (d, 8H, OCH2CO), 4.66-4.78 (d, m, 4H+4H, Hax ArCH2Ar, CHN), 
6.75 (s, 8H, aromatic CH), 7.73 (d, 4H, NH); 13C, δ 27.57 (CHCH2CH2), 30.81 (CHCH2COO), 31.98 
(Me3C), 32.51 (ArCH2Ar), 34.52 (Me3C), 52.05 (CHN), 52.29, 53.04 (OMe), 74.76 (OCH2CO), 126.11, 
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126.54, 133.28, 134.06 (aromatic CH), 146.23, 153.36 (aromatic C), 170.74 (CONH), 173.13, 173.75 
(COOMe). 
The methyl ester of 2 was hydrolysed as above, and isolated as a white powder after recrystallisation 
from thf/diethyl ether to yield 2 in 66% yield. (Found: C, 61.55; H, 6.64; N, 3.21. C72H92O24N4.H2O.thf 
requires C, 61.36; H, 6.91; N, 3.77%). 
 
Calcium carbonate. The impact of additives on the morphology of calcium carbonate was 
investigated using a method adapted from that of Gower and Tirrell.24 Vials containing calcium chloride 
solutions (20 mL, 7 mmol) with appropriate concentrations of additives, were placed in a sealed 
desiccator (~20 cm diameter), along with vials of ammonium carbonate. The vials were covered with 
laboratory film, with pin-holes to allow diffusion of ammonia and carbon dioxide. Microscope 
coverslips (11 mm diameter) were placed in the calcium chloride solutions to simplify recovery of the 
crystals for microscopy. After five days, the crystals were recovered, briefly washed with water, and 
allowed to dry. After gold-coating, the crystals were examined in a scanning electron microscope. 
Autonucleated calcium carbonate precipitation was monitored using a nephelometer probe (Analite 
NEP 160 from McVan Instruments) with a 90° detector. The reactor was stirred at 300 rpm using an 
overhead stirrer. The solution composition was 15 mM NaHCO3 and 19 mM CaCl2, with the required 
additive concentration.  
Barium sulfate. Barium sulfate precipitation experiments were carried out as described previously.25 
Briefly, precipitation of barium sulfate was monitored in situ using conductivity. The desupersaturation 
rate was determined as the slope of the linear section of the desupersaturation curve after the induction 
period. A thermostatted reaction vessel, with glass stirring rod, containing barium chloride (~0.25 mM) 
solution was allowed to equilibrate before equivalent sodium sulfate was rapidly added to commence 
the precipitation reaction. The organic additive was added to the initial barium chloride solution at 
concentrations ranging from 0 to 3.8 µM. Solids were filtered at the end of the run using a 0.2µm 
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membrane, washed with MilliQ water and dried in a dessicator before being prepared for SEM. For 
those runs where precipitation did not occur on the timescale of the experiment, the solution was left for 
>3 days with a clean glass cover slip at the bottom of the vessel. The glass cover slip was then removed, 
washed and dried for SEM. 
Calcium Oxalate. Calcium oxalate crystals were produced following a literature method reported to 
produce the monohydrate (COM).26 In brief, calcium chloride solution was combined with a potassium 
oxalate solution, in an acetate buffer, to give final concentrations of calcium chloride, 4 x 10-3 M, and 
potassium oxalate, 0.2 x 10-3 M. Crystal growth took place over a 48-72 hour period .The additive was 
introduced over a range of concentrations. The crystals were gold coated and examined in the SEM.  
RESULTS AND DISCUSSION 
Additive Synthesis. Calixarenes 1 and 2 were synthesized following well established procedures, 
commencing with the p-tert-butylcalix[4]arene functionalized at the lower rim with acid chloride 
moieties.23 Reaction with the appropriate amino acid methyl ester gave the amino acid functionalized 
products in reasonable yield. These methyl ester were readily characterized using nmr spectroscopy, 
with the appearance of the calixarene methylene resonances as a pair of doublets,27 and the chemical 
shift of the methylene carbon in the 13C spectrum,28 confirming that the macrocycle is in the cone 
conformation. After mild hydrolysis to deprotect the amino acid moieties without hydrolyzing the amide 
links,29 the nmr spectra were significantly broadened. Nevertheless, it was clear that the ester methyl 
groups are absent in the final products. With stoichiometric addition of sodium hydroxide, both 1 and 2 
are sufficiently soluble to use as crystal growth modifiers in aqueous systems.  
Calcium Carbonate Crystallization. Calcium carbonate was crystallized by slow diffusion of carbon 
dioxide and ammonia (produced by ammonium carbonate) into calcium chloride solutions. In the 
absence of the calixarene additives, typical calcite rhombs bounded by {10.4} faces were obtained, with 
the occasional appearance of spherical vaterite agglomerates (Figure 1). With the addition of either of 
the calixarene additives, we detected only calcite, based on direct observation of the crystal 
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morphologies and also IR spectroscopy. In the presence of the aspartic acid functionalized calixarene 1, 
even at concentrations as low as 0.37 µM, changes in the morphology of the calcite are apparent, with 
notches in the rhomb edges, progressing to “studded” crystals at higher additive concentrations, where 
over-growth appears to have taken place on the six rhombohedral surfaces (Fig 1). Aspartic acid 
monomer, added at equivalent concentrations, did not induce any changes relative to the blank.  
A similar morphology to that observed here has been reported for calcite grown in the presence of a 
helical peptide, modified from an antifreeze peptide by the introduction of aspartic acid residues.10 The 
studded morphology is reported to form under conditions where the peptide is only 40% helical, and 
was also found for a number of other polyanionic systems with poorly ordered structures, leading to the 
suggestion that this morphology results from the calcite surface binding polyanions with no regular 
conformation. Interestingly, fluorescein labeling showed that this peptide was incorporated into the 







Figure 1. Scanning electron micrographs of calcite crystals grown in the presence of 1. (a) Blank, (b) 
0.37 µM, mole ratio of 1 : Ca = 1 : 19000, (c) 0.74 µM, 1 : Ca = 1 : 9500, and (d) 1.5 µM, 1 : Ca = 1 : 
4700. 
Calcite crystals grown in the presence of the glutamic acid functionalized additive 2, exhibited 
significantly different morphologies, and required higher additive levels to achieve a large impact. Once 
again, however, equivalent concentrations of the glutamic acid monomer had no discernible impact on 
the crystal morphology. Two new stepped crystal faces are quite clearly expressed in the modified 
crystals, and the new faces become increasingly dominant with increasing additive concentration 
(Figure 2). Amino acids, including aspartic acid, have been reported to bind selectively to the acute 
steps on the {10.4} face,30 and similar behaviour is observed here, as shown clearly in Figure 2(c) where 
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new stepped faces are much more apparent on the upper faces of the crystal than the lower. The new 
faces were assigned by comparison of the micrographs with computer-generated morphologies, and by 
comparison with literature. The new edge faces are tentatively assigned as {11.0} faces, and the corner 
faces as {01.2}, although it is noted that these faces are severely roughened. These crystals are similar 
to those produced in the presence of proteins isolated from biological systems such as sea urchin 
spicules and mollusk shells, where {01.l} faces in particular have been observed in a number of 
systems.7 A remarkably similar morphology has also been reported for calcite grown in the presence of 
an amphiphilic peptide containing alternating Asp and Phe residues, which is reported as the first 
peptide that selectively interacts with two different calcite faces.11 The fact that calixarene 2 appears to 
stabilise the same crystal faces, whilst comprising of a completely different structure, requires further 
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Figure 2. Scanning electron micrographs of calcite crystals grown in the presence of 2. (a) 1.4 µM, 
mole ratio of 2 : Ca = 1 : 5000 (b) 7.1 µM, 2 : Ca = 1 : 1000, (c) 10 µM, 2 : Ca = 1 : 700, and (d) 13 
µM, 2 : Ca = 1 : 540. 
Autonucleation of the calcium carbonate in the presence of the two additives was studied using in situ 
nephelometry. Both calixarene additives induced a significant lengthening in the induction period 
(Figure 3). It is interesting to note, however, that the glutamic acid derivative 2, appears to suppress 
growth over a longer time period than the aspartic additive 1, despite the fact that 1 has a much greater 
impact on calcite morphology at lower concentrations when compared to the impact of 2. These results, 
in combination with the “studded” morphology found in the presence of 1 (Figure 1), suggest that 1 may 
be incorporated into the growing calcium carbonate crystals. This may lead to increased crystal growth 
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once the solution concentration of the additive is depleted, and would also allow the recovery of the 
{10.4} faces in the slow growth experiments. Further work will be required to investigate this 
hypothesis.  
 
Figure 3. The change in light scattering of supersaturated calcium carbonate solutions over time. Blank, 
squares; in the presence of 1, circles; in the presence of 2, triangles (additive concentration = 1.5 µM).  
Barium Sulfate Crystallization. Additives 1 and 2 were also tested as barite crystal growth 
modifiers. Although small molecule barite inhibitors typically involve functional groups such as 
phosphates and phosphonates, we have observed previously that some small polycarboxylates can 
modify barite crystallization.13 Supersaturated solutions were produced by mixing barium chloride and 
sodium sulfate solutions, to give an initial barium sulfate concentration of 0.25 mM (supersaturation, 
ratio, ~25). Desupersaturation was monitored by logging conductivity, and the impact of the additives 




Figure 4. Desupersaturation rates for a barium sulfate solution (supersaturation ratio, ~25), with 
increasing concentrations of additives 1 and 2.  
Both additives completely inhibited crystal growth at a concentration of 3.6 µM over the timescale of 
the experiment, and significantly reduced the growth rate at 0.75 µM. This compares favourably with 
the potent polyphosphonate additives we have investigated under comparable conditions, such as 









Figure 5. Scanning electron micrographs of barite crystals isolated after desupersaturation rate 
experiments. (a) Blank, (b) with 1 at 0.15 µM, (c) 1 at 0.75 µM, (d) 1 at 0.75 µM, (e) 2 at 0.15 µM, and 
(f) 2 at 0.75 µM.  
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Crystals were isolated at the end of the desupersaturation experiments, and the crystal morphologies 
examined in the scanning electron microscope. The blank system gave typical barite crystals with the 
rectangular morphology containing end (001) faces and rounded (hk0) faces. In the presence of additive 
1, significantly altered morphologies were observed, consistent with the substantial growth inhibition 
achieved. The barite appears to be polycrystalline in all cases, and at 0.75 µM additive concentration 
some clusters exhibit elongated morphologies (Figure 5c), and others are agglomerates of smaller 
crystals with morphologies comparable to the blank system (Figure 5d). The glutamic derivative 2 
induces much smaller changes at the lowest concentration (Figure 5e) consistent with a lack of growth 
inhibition (Figure 4), although some polycrystallinity is indicated in the micrograph. At 0.75 µM of 2, 
the barite crystal clusters are comparable to those produced in the presence of 1 (Figure 5f).  
Polyaspartic acid of varying molecular weight has been investigated as a barium sulfate inhibitor 
previously.31 This work showed that inhibition by polyaspartic acid is comparable to polyacrylates and 
optimal inhibition occurred when 15-30 monomer units formed the polymer (in fact in the presence of 
1.56 µM of a 3,200 MW polyaspartic acid, barite precipitation was inhibited by 78% - this represents 24 
monomer units each with one carboxylate group). In the present work described, 4 monomer units of 
aspartic acid are bound to the calixarene, each with two carboxylate groups, and 3.6 µM is sufficient to 
completely inhibit precipitation. Thus, in terms of concentration of carboxylate moieties, polyaspartic 
acid achieved 78% inhibition at 37.4 µM, whereas the calixarene 1 achieved 100% inhibition at 28.8 
µM. This implies that, in fact, the aspartic acid functionalized calixarene is a more potent crystal growth 
inhibitor than polyaspartic acid. Conducting a barite precipitation run in the presence of aspartic acid at 
17 µM (a higher concentration than the equivalent aspartic acid present in a 3.6 µM solution of 1) 
showed only a marginal reduction in de-supersaturation rate (control ~ -3.0x10-5 mSs-1, with aspartic 
present ~ -2.3x10-5 mSs-1). To the best of the authors’ knowledge there is no literature showing the same 
morphological changes to barite as those observed here. Certainly, polymers have been shown to 
produce polycrystalline structures, which can self-aggregate to form more complex shapes.32 
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Unfortunately, the paper reporting the impact of polyaspartic acid, discussed above, contains no 
images.31 
 
Calcium Oxalate Crystallization. Calcium oxalate is a biomineral found in plants, and is a 
constituent of kidney stones.33, 34 The interaction of proteins and the inorganic component in kidney 
stones is an area of significant interest,35 and hence it was of interest to compare the impact of additives 
1 and 2 on the crystal growth of calcium oxalate. Calcium oxalate typically crystallizes as one of three 
hydrates; the thermodynamically stable monohydrate (COM), and the metastable dihydrate (COD) and 
trihydrate (COT).34 We have shown previously that additive 1 stabilizes COD under conditions where 
COM is otherwise produced.22 A typical COM crystal produced in the absence of additives is shown in 
Figure 6(a). The morphology of COD crystallized in the presence of 1 is shown in Figure 6(b), with 
relatively smooth pyramidal {101} faces, and severely roughened prismatic {100} faces. As the 
concentration of 1 is increased, the COD crystals lengthen slightly and the {101} faces roughen (not 
shown). For concentrations of 2.2 µM and higher, the crystals formed were predominantly COD, 
although the additive appears to inhibit nucleation effectively, and the number of crystals formed 
dropped significantly with increasing additive concentration. We confirmed the assignment of the phase 
of these crystals, and samples mentioned below, using Raman microscopy to collect spectra of 










Figure 6. Scanning electron micrographs of calcium oxalate crystals isolated in the presence of 
calixarene additives 1 and 2. (a) Blank, (b) with 1 at 2.2 µM, (c) 2 at 1.4 µM, (d) 2 at 2.9 µM, (e) 2 at 
7.2 µM, and (f) 2 at 11 µM.  
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Calcium oxalate crystallized in the presence of glutamic calixarene 2 exhibited different behaviour. 
The crystalline product was dominated by COM, albeit with altered morphologies up to concentrations 
of 7.2 µM. The COM was found either as clusters of thin plates (Figure 6c, e), or as severely roughened, 
possibly polycrystalline deposits with an overall morphology comparable to that of COM found in the 
blank (Figure 6d). Further increase of the additive concentration resulted in the formation of COD 
crystals comparable to those produced in the presence of 1 (Figure 6f), although once again, significant 
inhibition was observed with very few crystals produced.  
These observations are comparable to those reported for the crystallization of calcium oxalate in the 
presence of polyaspartic and polyglutamic acids.37 Polyaspartic acid is reported to stabilize COD (most 
effective molecular weight range 12 – 15 kDa), although in this case no elongation of the COD 
bipyramids was apparent (based on optical microscopy observations). Polyglutamic acid (13 kDa) 
induced altered morphologies of COM, described as dumbbell-like, again based on optical micrographs. 
At higher concentrations of polyglutamic acid, COD was formed as bipyramids. A carboxylated block 
copolymer has been reported to produce elongated COD crystals with dominant {100} faces.34 
Interestingly, the {100} faces in these crystals appear smooth, whereas the two calixarene additives 
induce significant roughening of these faces.  
CONCLUSION 
The impact of two amino acid functionalized calixarenes on the crystal growth of three different 
inorganic systems has been investigated. The results indicate that these relatively low molecular weight 
additives can induce changes comparable to those achieved by much larger polymeric additives with 
similar functional groups. In some cases, the changes in morphology are remarkably similar to those 
produced in the presence of proteins derived from natural systems. Work is now underway to study 
these additives in more detail, using a combination of computational studies, and further experimental 
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Calix[4]arenes, functionalized at the lower rim with aspartic or glutamic acid, are found to be potent 
crystal growth modifiers for inorganic crystals, including calcite, barite and calcium oxalate. The impact 
of these novel crystal growth modifiers is found to be comparable to polymers and proteins, of much 
higher molecular weight in some cases, in terms of morphology modification and phase deposited.  
  
